StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Friday morning. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of BLPH opened at $0.04 on Friday. The firm’s 50-day simple moving average is $0.04 and its 200 day simple moving average is $0.05. The firm has a market cap of $428,050.00, a P/E ratio of -0.04 and a beta of 0.70. Bellerophon Therapeutics has a 52 week low of $0.03 and a 52 week high of $0.46.
About Bellerophon Therapeutics
Featured Articles
- Five stocks we like better than Bellerophon Therapeutics
- What Are Dividend Challengers?
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- Retail Stocks Investing, Explained
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- What is the Euro STOXX 50 Index?
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.